Alamast; Pemilaston; Pemirolast potassium salt; BMY 26517; UNII-497A17OUUE; BMY-26517; Alegysal; TWT-8152; 497A17OUUE; 100299-08-9 (potassium); potassium 5-(9-methyl-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)tetrazol-1-ide; DSSTox_CID_26623; DSSTox_RID_81773; DSSTox_GSID_46623; 9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidin-4-one potassium salt; 9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one Potassium Salt; CCRIS 3562; Pemirolast potassium [USAN:JAN]; NCGC00167434-01; Pemilaston (TN); Alegysal (TN); Alamast (TN); 9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido(1,2-a)pyrimidin-4-one, potassium salt; Alamast, Pemirolast potassium; C10H7KN6O; SCHEMBL865789; CHEMBL1201050; DTXSID7046623; CTK8E7454; HMS3713G17; BCP21138; Pemirolast potassium (JP17/USAN); Tox21_112438; BDBM50248065; DE-068; Pemirolast (BMY 26517) potassium; s4008; AKOS015901748; Tox21_112438_1; AC-8303; CCG-220358; HS-0020; Pemirolast potassium, >=98% (HPLC); SB18793; VA11504; 4H-Pyrido(1,2-a)pyrimidin-4-one, 9-methyl-3-(1H-tetrazol-5-yl)-, potassium salt; NCGC00167434-02; AC-22387; FT-0631005; P1995; P2547; D01088; 299P089; J-000087; Q27259246